Medical Marijuana for Rheumatoid Arthritis

What is Rheumatoid Arthritis?

Rheumatoid arthritis (RA) is a chronic autoimmune disease in which the body's immune system attacks the synovium (the membrane lining the joints), causing inflammation, pain, swelling, stiffness, and progressive joint damage. RA typically affects the small joints of the hands and feet symmetrically, often with morning stiffness lasting more than an hour. Untreated, RA can cause permanent joint deformity, bone erosion, and significant disability. Extra-articular manifestations include rheumatoid nodules, interstitial lung disease, vasculitis, and accelerated cardiovascular disease.

Does cannabis help Rheumatoid Arthritis?

Cannabis is not a disease-modifying treatment for rheumatoid arthritis. Disease modification (slowing or halting joint damage) requires DMARDs and biologics under rheumatologist supervision. The 2017 NASEM consensus report did not identify high-tier evidence for cannabis as a treatment for RA disease activity.

Cannabis evidence is stronger for RA-related symptoms:

• Chronic pain: the NASEM substantial-evidence finding for chronic pain in adults applies to RA-related pain.
• Sleep disturbance: moderate evidence supports cannabis use for sleep problems, which are common in RA.
• Mood symptoms: anxiety and depression often co-occur with RA; cannabis effects on these are mixed in the literature.

Preclinical data on cannabinoid effects in animal models of arthritis (CB2-receptor-mediated anti-inflammatory effects) has not translated to consistent clinical benefit in RA patients.

Practical considerations

Cannabis should be used adjunctively rather than as a substitute for DMARD or biologic therapy. Patients should coordinate cannabis use with their rheumatologist, particularly when also taking methotrexate, JAK inhibitors, or biologics (potential immune-modulatory interactions are incompletely characterized).

Drug interactions include additive CNS depression with opioids, gabapentinoids, and benzodiazepines. Cannabis-induced tachycardia may complicate cardiovascular risk in patients with RA-associated atherosclerosis. Smoked cannabis is contraindicated in patients with RA-associated interstitial lung disease.

Important: RA is a progressive disease that requires early and aggressive disease-modifying treatment to prevent joint damage. Patients should not substitute cannabis for prescribed DMARDs or biologics. The cannabis benefit in RA is symptom management, not disease control.